AIDSPub Date : 2024-09-01Epub Date: 2024-05-30DOI: 10.1097/QAD.0000000000003944
Jingjing Zhao, Xiaojun Zhou, Yefeng Qiu, Rui Jia
{"title":"Characterization of the gut butyrate-producing bacteria and lipid metabolism in African green monkey as a natural host of simian immunodeficiency virus infection.","authors":"Jingjing Zhao, Xiaojun Zhou, Yefeng Qiu, Rui Jia","doi":"10.1097/QAD.0000000000003944","DOIUrl":"10.1097/QAD.0000000000003944","url":null,"abstract":"<p><strong>Objective: </strong>Natural hosts of simian immunodeficiency virus (SIV), such as the African green monkey (AGM), possess the ability to avoid acquired immune deficiency syndrome (AIDS) despite lifelong infection. The underlying mechanisms are not completely understood. This study aimed to characterize the gut microbiome and metabolite profiles of different nonhuman primates (NHPs) to provide potential insight into AIDS resistance.</p><p><strong>Design and methods: </strong>Fresh feces from Cynomolgus macaques (CMs), and Rhesus macaques (RMs), SIV- AGMs (AGM_N), and SIV+ AGMs (AGM_P) were collected and used for metagenomic sequencing and metabonomic analysis.</p><p><strong>Results: </strong>Compared with CMs and RMs, significant decreases in the abundances of Streptococcus , Alistipes , Treponema , Bacteroides , and Methanobrevibacter ( P < 0.01), and significant increases in the abundances of Clostridium , Eubacterium , Blautia , Roseburia , Faecalibacterium , and Dialister ( P < 0.01) were detected in AGM_N. Compared with AGM_N, a trend toward increased abundances of Streptococcus and Roseburia were found in AGM_P. The levels of metabolites involved in lipid metabolism and butanoate metabolism significantly differed among AGM_P, AGM_N and CM ( P < 0.05).</p><p><strong>Conclusions: </strong>Our data, for the first time, demonstrated distinguishing features in the abundances of butyrate-producing bacteria and lipid metabolism capacities between different NHP hosts of SIV infection. These findings may correlate with the different characteristics observed among these hosts in the maintenance of intestinal epithelial barrier integrity, regulation of inflammation, and provide insights into AIDS resistance in AGMs.</p>","PeriodicalId":7502,"journal":{"name":"AIDS","volume":" ","pages":"1617-1626"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141178661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
AIDSPub Date : 2024-09-01Epub Date: 2024-06-24DOI: 10.1097/QAD.0000000000003956
Olutomi Sodeke, Kyle Milligan, Ijeoma Ezeuko, Ademola Oladipo, Anuri Emeh, Adebobola Bashorun, Oluwaniyi Orisawayi, Sanda Danjuma, Dennis Onotu, Adetinuke Mary Boyd, Andrew Abutu, Helen Chun, Snigdha Vallabhaneni
{"title":"Longitudinal viral load outcomes of adults with HIV after detectable viremia on tenofovir, lamivudine, and dolutegravir.","authors":"Olutomi Sodeke, Kyle Milligan, Ijeoma Ezeuko, Ademola Oladipo, Anuri Emeh, Adebobola Bashorun, Oluwaniyi Orisawayi, Sanda Danjuma, Dennis Onotu, Adetinuke Mary Boyd, Andrew Abutu, Helen Chun, Snigdha Vallabhaneni","doi":"10.1097/QAD.0000000000003956","DOIUrl":"10.1097/QAD.0000000000003956","url":null,"abstract":"<p><strong>Background: </strong>To inform optimal management of HIV viremia on tenofovir, lamivudine, and dolutegravir (TLD), we examined viral load (VL) outcomes of a large cohort of adult PWH on TLD in Nigeria.</p><p><strong>Methods: </strong>We conducted a retrospective study of adult PWH who had ≥1 VL after initiating TLD during January 2017-February 2023. VLs were categorized as undetectable (≤50 copies/ml), low low-level viremia (LLV, 51-199 copies/ml), high LLV (200-999 copies/ml), virologic nonsuppression (VLNS, ≥1000 copies/ml), and virologic failure (VF, ≥2 consecutive VLNS results). Among patients with ≥2 VLs on TLD, we described how viremia changed over time and examined virologic outcomes after VF. We identified predictors of subsequent VLNS using mixed-effects logistic regression and conducted planned contrasts between levels of VL result and regimen types.</p><p><strong>Results: </strong>Analysis of 82,984 VL pairs from 47,531 patients demonstrated viral resuppression to ≤50 copies/ml at follow-up VL in 66.7% of those with initial low LLV, 59.1% of those with initial high LLV, and 48.9% of those with initial VLNS. Of 662 patients with a follow-up VL after VF, 94.6% stayed on TLD; of which 57.8% (359/621) were undetectable at next VL without regimen change. Previous low LLV [adjusted odds ratio (aOR) 1.74, 1.56-1.93], high LLV (aOR 2.35, 2.08-2.65), and VLNS (aOR 6.45, 5.81-7.16) were associated with increasingly higher odds of subsequent VLNS, whereas a previously undetectable VL (aOR 1.08, 0.99-1.71) on TLD was not.</p><p><strong>Conclusions: </strong>Despite increased odds of subsequent VLNS, most PWH with detectable viremia on TLD, including those with VF, will resuppress to an undetectable VL without a regimen change.</p>","PeriodicalId":7502,"journal":{"name":"AIDS","volume":" ","pages":"1714-1719"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11293980/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141316504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
AIDSPub Date : 2024-09-01Epub Date: 2024-07-02DOI: 10.1097/QAD.0000000000003973
Elizabeth Marie King, Stacey Tkachuk, Alice Tseng
{"title":"Aging on antiretrovirals: reviewing the need for pharmacologic data in elderly people with HIV.","authors":"Elizabeth Marie King, Stacey Tkachuk, Alice Tseng","doi":"10.1097/QAD.0000000000003973","DOIUrl":"10.1097/QAD.0000000000003973","url":null,"abstract":"","PeriodicalId":7502,"journal":{"name":"AIDS","volume":" ","pages":"1609-1616"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11296272/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141490531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
AIDSPub Date : 2024-08-29DOI: 10.1097/QAD.0000000000003999
Timothy N Crawford, Torsten B Neilands, Lydia N Drumright, Rob J Fredericksen, Mallory O Johnson, Kenneth H Mayer, Laura Bamford, Abigail W Batchelder, Heidi M Crane, Latesha Elopre, Richard D Moore, A Lina Rosengren, Katerina A Christopoulos
{"title":"Internalized HIV stigma and viral suppression: examining the mediating and moderating roles of substance use and social support.","authors":"Timothy N Crawford, Torsten B Neilands, Lydia N Drumright, Rob J Fredericksen, Mallory O Johnson, Kenneth H Mayer, Laura Bamford, Abigail W Batchelder, Heidi M Crane, Latesha Elopre, Richard D Moore, A Lina Rosengren, Katerina A Christopoulos","doi":"10.1097/QAD.0000000000003999","DOIUrl":"10.1097/QAD.0000000000003999","url":null,"abstract":"<p><strong>Objective: </strong>To examine the effects of internalized HIV stigma on viral non-suppression via depressive symptoms, alcohol use, illicit drug use, and medication adherence and investigate whether social support moderates these effects.</p><p><strong>Design: </strong>Longitudinal observational clinical cohort of patients in HIV care in the US.Methods: Data from the CFAR Network for Integrated Clinical Systems (2016-2019) were used to conduct structural equation models (SEM) to test the indirect effects of internalized HIV stigma on viral non-suppression through depressive symptoms, illicit drug use, alcohol use, and medication adherence. Moderated mediation with an interaction between social support and internalized HIV stigma was examined.</p><p><strong>Results: </strong>Among 9,574 individuals included in the study sample, 81.1% were male and 41.4% were Black, non-Hispanic. The model demonstrated good fit (root mean square error of approximation = 0.028; standardized root means square residual = 0.067). The overall indirect effect was significant (b = 0.058; se = 0.020; β = 0.048; 95%CI = .019-.098), indicating that internalized HIV stigma's impact on viral non-suppression was mediated by depressive symptoms, illicit drug use, and medication adherence. An interaction was observed between internalized HIV stigma and social support on alcohol use, however, there was no moderated mediation for any of the mediators.</p><p><strong>Conclusions: </strong>Internalized HIV stigma indirectly impacts viral non-suppression through its effects on depressive symptoms, illicit drug use, and medication adherence. Social support may buffer the impact, but more research is needed. Understanding the pathways through which internalized stigma impacts viral suppression is key to improving health of people with HIV.</p>","PeriodicalId":7502,"journal":{"name":"AIDS","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142103434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
AIDSPub Date : 2024-08-14DOI: 10.1097/QAD.0000000000003995
Montserrat Capell-Morell, Melissa Bradbury, Maria Carme Dinares, Javier Hernandez, Montserrat Cubo-Abert, Cristina Centeno-Mediavilla, Antonio Gil-Moreno
{"title":"Anal high-grade intraepithelial neoplasia and cancer in women living with HIV and HIV-negative women with other risk factors.","authors":"Montserrat Capell-Morell, Melissa Bradbury, Maria Carme Dinares, Javier Hernandez, Montserrat Cubo-Abert, Cristina Centeno-Mediavilla, Antonio Gil-Moreno","doi":"10.1097/QAD.0000000000003995","DOIUrl":"https://doi.org/10.1097/QAD.0000000000003995","url":null,"abstract":"<p><strong>Objective: </strong>To determine the prevalence and the risk factors for anal high-grade intraepithelial neoplasia and anal cancer (HSIL+) in women living with HIV (WLWHIV), and to compare them to HIV-negative women with other risk factors.</p><p><strong>Design: </strong>Prospective cohort study.</p><p><strong>Methods: </strong>WLWHIV and HIV-negative women with other risk factors were included. Screening for anal HSIL+ using anal cytology and HPV testing was performed. A high-resolution anoscopy with directed biopsy was also performed in patients with an abnormal cytology result or a positive HPV testing for high-risk (HR) genotypes, and in those with anal symptoms.</p><p><strong>Results: </strong>The period prevalence of anal HR-HPV infection and histological HSIL was 57.9% and 10.9% among WLWHIV, and 60.8% and 9.2% among HIV-negative women. The prevalence of anal HPV 18 infection was higher in WLWHIV. The risk factors for anal HSIL+ in WLWHIV included anal HPV 16, other HR genotypes and low-risk genotypes infection, as well as a history of vulvar HSIL+. In HIV-negative women, the risk factors included anal HPV 16 infection, history of anogenital warts and of vulvar HSIL+, and immunosuppressive treatment.</p><p><strong>Conclusions: </strong>A high prevalence of anal HPV infection and HSIL was observed in WLWHIV and women with other risk factors. Both groups share anal HPV 16 infection and history of vulvar HSIL+ as risk factors for the development of anal HSIL+. Genotyping for anal HPV 16 may help identify women at higher risk of anal cancer.</p>","PeriodicalId":7502,"journal":{"name":"AIDS","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142016065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
AIDSPub Date : 2024-08-09DOI: 10.1097/QAD.0000000000003992
Monica M Diaz, J Allen Mccutchan, Melanie Crescini, Bin Tang, Donald Franklin, Scott L Letendre, Robert K Heaton, Ajay R Bharti
{"title":"Longitudinal Study of Cognitive Function in People with HIV and Toxoplasmic Encephalitis or Latent toxoplasma Infection.","authors":"Monica M Diaz, J Allen Mccutchan, Melanie Crescini, Bin Tang, Donald Franklin, Scott L Letendre, Robert K Heaton, Ajay R Bharti","doi":"10.1097/QAD.0000000000003992","DOIUrl":"10.1097/QAD.0000000000003992","url":null,"abstract":"<p><strong>Background: </strong>Neurocognitive impairment (NCI) may occur during and persist even after recovery from HIV-related CNS co-infections such as toxoplasmic encephalitis (TE). The long-term cognitive effects of TE and latent toxoplomasmic infections (LTI) among persons with HIV (PWH) are unknown. We measured longitudinal effects on NC functioning in PWH with TE compared to LTI or no toxoplasmal infection.</p><p><strong>Methods: </strong>PWH (n = 345) followed in two longitudinal cohort studies underwent comprehensive neurocognitive assessments and an anti-Toxoplamic IgG assay. Participants were classified into one of three groups: TE+ (n = 39), LTI+ (n = 34), LTI- (n = 272). The primary outcome was change in neurocognitive function between baseline and 7-year visit.</p><p><strong>Results: </strong>The mean age was 48 ± 11 years, mean educational level 13 ± 3 years, and 13% were female. TE+ patients were less likely to have undetectable viral loads (≤50 copies/mL) and had lower absolute CD4 counts. The TE+ group had the highest prevalence of NCI globally and in domains of verbal, executive function, learning, recall, working memory, processing speed and motor at baseline and at 7-year follow-up. Changes in longitudinal NC function over 7 years were small and did not differ significantly among all groups, except that speed of information processing improved more in TE+ compared with LTI- participants.</p><p><strong>Conclusions: </strong>PWH with a history of TE had cognitive impairment over a broad range of severity at both baseline and last follow-up. Changes in cognition from baseline to last examination in all groups were minimal and did not differ significantly among the groups with the exception of speed of information processing.</p>","PeriodicalId":7502,"journal":{"name":"AIDS","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141905542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
AIDSPub Date : 2024-08-01Epub Date: 2024-05-28DOI: 10.1097/QAD.0000000000003940
Alexandria C Smith, Joseph L Goulet, David Vlahov, Amy C Justice, Julie A Womack
{"title":"Self-injurious unnatural death among Veterans with HIV.","authors":"Alexandria C Smith, Joseph L Goulet, David Vlahov, Amy C Justice, Julie A Womack","doi":"10.1097/QAD.0000000000003940","DOIUrl":"10.1097/QAD.0000000000003940","url":null,"abstract":"<p><strong>Objective: </strong>People with HIV (PWH) are at an increased risk of suicide and death from unintentional causes compared with people living without HIV. Broadening the categorization of death from suicide to self-injurious unnatural death (SIUD) may better identify a more complete set of modifiable risk factors that could be targeted for prevention efforts among PWH.</p><p><strong>Design: </strong>We conducted a nested case-control study using data from the Veterans Aging Cohort Study (VACS), a longitudinal, observational cohort of Veterans from 2006-2015. A total of 5036 Veterans with HIV, of whom 461 died by SIUD, were included in the sample.</p><p><strong>Methods: </strong>SIUD was defined using the International Classification of Disease 10 th revision cause of death codes. Cases ( n = 461) included individuals who died by SIUD (intentional, unintentional, and undetermined causes of death). Controls ( n = 4575) were selected using incidence density sampling, matching on date of birth ± 1 year, race, sex, and HIV status. SIUD and suicide was estimated using conditional logistic regression.</p><p><strong>Results: </strong>A previous suicide attempt, a diagnosis of an affective disorder, recent use of benzodiazepines, psychiatric hospitalization, and living in the western US significantly increased the risk of suicide and SIUD. Risk factors that appear more important for SIUD than for suicide included a drug use disorder, alcohol use disorder, Hepatitis C, VACS Index 2.0, current smoking, and high pain levels (7-10).</p><p><strong>Conclusion: </strong>Limiting studies to known suicides obscures the larger public health burden of excess deaths from self-injurious behavior. Our findings demonstrate the benefit of expanding the focus to SIUD for the identification of modifiable risk factors that could be targeted for treatment.</p>","PeriodicalId":7502,"journal":{"name":"AIDS","volume":" ","pages":"1570-1578"},"PeriodicalIF":3.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141174277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
AIDSPub Date : 2024-08-01Epub Date: 2024-07-11DOI: 10.1097/QAD.0000000000003941
Shokrollah Elahi
{"title":"Galectin-9, a lingering shadow in HIV's fight: the unseen battle of adolescents with perinatally-acquired HIV.","authors":"Shokrollah Elahi","doi":"10.1097/QAD.0000000000003941","DOIUrl":"10.1097/QAD.0000000000003941","url":null,"abstract":"","PeriodicalId":7502,"journal":{"name":"AIDS","volume":"38 10","pages":"1589-1591"},"PeriodicalIF":3.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141578711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
AIDSPub Date : 2024-08-01Epub Date: 2024-05-23DOI: 10.1097/QAD.0000000000003936
Rachel L Goldberg, Tess E Peterson, Sabina A Haberlen, Mallory D Witt, Frank J Palella, Jared W Magnani, Todd T Brown, Jordan E Lake, Joao A C Lima, Matt J Budoff, Chiadi E Ndumele, Katherine C Wu, Wendy S Post
{"title":"Associations between epicardial, visceral, and subcutaneous adipose tissue with diastolic function in men with and without HIV.","authors":"Rachel L Goldberg, Tess E Peterson, Sabina A Haberlen, Mallory D Witt, Frank J Palella, Jared W Magnani, Todd T Brown, Jordan E Lake, Joao A C Lima, Matt J Budoff, Chiadi E Ndumele, Katherine C Wu, Wendy S Post","doi":"10.1097/QAD.0000000000003936","DOIUrl":"10.1097/QAD.0000000000003936","url":null,"abstract":"<p><strong>Background: </strong>People with HIV (PWH) are at greater risk for diastolic dysfunction compared with persons without HIV (PWOH). An increase in visceral adipose tissue is common among PWH and greater visceral adipose tissue is associated with diastolic dysfunction among PWOH. We investigated associations of visceral adipose tissue, subcutaneous adipose tissue, and other fat depots with subclinical diastolic dysfunction among men with and without HIV (MWH and MWOH).</p><p><strong>Design: </strong>Cross-sectional analysis of MWH and MWOH in the Multicenter AIDS Cohort Study (MACS).</p><p><strong>Methods: </strong>Participants underwent echocardiography for diastolic dysfunction assessment and CT scanning including subcutaneous, visceral, epicardial, and liver adiposity measurements. Diastolic dysfunction was defined by characterizing heart function on antiretroviral therapy0 criteria. Odds for diastolic dysfunction with each measure of adiposity were estimated using multivariable logistic regression.</p><p><strong>Results: </strong>Among 403 participants (median age 57, 55% white, median BMI 26 kg/m 2 ), 25% met criteria for diastolic dysfunction and 59% MWH (82% undetectable plasma HIV RNA). Greater epicardial adipose tissue area was associated with higher odds of diastolic dysfunction [odds ratio:1.54 per SD; 95%confidence interval (CI) 1.15-2.05] when adjusted for demographics, HIV serostatus, and cardiovascular risk factors. This association did not differ by HIV serostatus and persisted when excluding MWH who were not virally suppressed. Less subcutaneous adipose tissue was associated with higher odds of diastolic dysfunction. Other adipose depots were not associated with diastolic dysfunction.</p><p><strong>Conclusion: </strong>Greater epicardial adipose tissue and less subcutaneous adipose tissue were associated with diastolic dysfunction, regardless of HIV serostatus and viral suppression. Greater epicardial adipose tissue and less subcutaneous adipose tissue observed among PWH may contribute to risk for heart failure with preserved ejection fraction in this population.</p>","PeriodicalId":7502,"journal":{"name":"AIDS","volume":" ","pages":"1485-1493"},"PeriodicalIF":3.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11404677/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141092261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
AIDSPub Date : 2024-08-01Epub Date: 2024-06-10DOI: 10.1097/QAD.0000000000003939
Christine Njuguna, Lawrence Long, Preethi Mistri, Candice Chetty-Makkan, Brendan Maughan-Brown, Alison Buttenheim, Laura Schmucker, Sophie Pascoe, Harsha Thirumurthy, Cara O'Connor, Chipo Mutyambizi, Barry Mutasa, Kate Rees
{"title":"A randomized trial of 'fresh start' text messaging to improve return to care in people with HIV who missed appointments in South Africa.","authors":"Christine Njuguna, Lawrence Long, Preethi Mistri, Candice Chetty-Makkan, Brendan Maughan-Brown, Alison Buttenheim, Laura Schmucker, Sophie Pascoe, Harsha Thirumurthy, Cara O'Connor, Chipo Mutyambizi, Barry Mutasa, Kate Rees","doi":"10.1097/QAD.0000000000003939","DOIUrl":"10.1097/QAD.0000000000003939","url":null,"abstract":"<p><strong>Objective: </strong>Treatment interruptions are a barrier to successful antiretroviral therapy (ART). 'Fresh start messages', which leverage significant days on the calendar (e.g., new year, public holiday) in order to prompt action, have the potential to encourage people with HIV (PWH) to return to care. We evaluated a 'fresh start' intervention (text messages) to increase return to care in PWH who had missed their last appointment.</p><p><strong>Design: </strong>A three arm 1 : 1:1 individual randomised controlled trial.</p><p><strong>Methods: </strong>We randomized adults in Capricorn District who had missed ART appointments by >28 days to: no text message; unframed messages (fresh start not mentioned); or framed messages (fresh start mentioned). Randomization was stratified by treatment interruption duration and across two holidays (Youth Day, Mandela Day). The primary outcome was an ART-related clinic visit at ≤45 days of the first message.</p><p><strong>Results: </strong>9143 participants were randomised. For Youth Day, 1474 and 1468 were sent unframed and framed messages respectively, with 13.4% sent these messages having an ART visit vs. 11.9% not sent a message [adjusted odds ratio (aOR) 1.2; 95% confidence interval (CI): 1.0-1.4, P -value = 0.075]. For Mandela Day, 1336 and 1334 were sent unframed and framed messages respectively, with 6.7% sent these messages having an ART-related clinic visit vs. 5.4% not sent a message (aOR 1.2; 95% CI: 1.0-1.6; P -value = 0.100).</p><p><strong>Conclusions: </strong>Low-cost text messages sent around a 'fresh start' date may increase the likelihood that patients who miss appointments return to care. This study suggests the potential of text messaging for motivating return to care.</p>","PeriodicalId":7502,"journal":{"name":"AIDS","volume":" ","pages":"1579-1588"},"PeriodicalIF":3.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11239091/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141174222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}